126 related articles for article (PubMed ID: 2883038)
1. Release of iron from endosomes is an early step in the transferrin cycle.
Bakkeren DL; de Jeu-Jaspars CM; Kroos MJ; van Eijk HG
Int J Biochem; 1987; 19(2):179-86. PubMed ID: 2883038
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of iron release from isolated heavy and light endosomes.
Bakkeren DL; De Jeu-Jaspars NM; Kroos MJ; van Eijk HG
Int J Biochem; 1988; 20(8):837-44. PubMed ID: 3169366
[TBL] [Abstract][Full Text] [Related]
3. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
Richardson DR; Ponka P
J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
[TBL] [Abstract][Full Text] [Related]
4. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.
Baker E; Vitolo ML; Webb J
Biochem Pharmacol; 1985 Sep; 34(17):3011-7. PubMed ID: 4038321
[TBL] [Abstract][Full Text] [Related]
5. Effect of pyridoxal isonicotinoyl hydrazone and analogs on iron metabolism in hepatocytes and macrophages in culture.
Richardson D; Baker E; Ponka P; Wilairat P; Vitolo ML; Webb J
Birth Defects Orig Artic Ser; 1988; 23(5B):81-8. PubMed ID: 3390577
[No Abstract] [Full Text] [Related]
6. A lipophilic iron chelator induces an enhanced proliferation of human erythroleukaemia (HEL) cells.
Ekblom P; Landschulz W; Andersson LC
Scand J Haematol; 1986 Mar; 36(3):258-62. PubMed ID: 3458297
[TBL] [Abstract][Full Text] [Related]
7. Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process.
Richardson DR
Biochim Biophys Acta; 1997 May; 1320(1):45-57. PubMed ID: 9186779
[TBL] [Abstract][Full Text] [Related]
8. The release of iron and transferrin from the human melanoma cell.
Richardson DR; Baker E
Biochim Biophys Acta; 1991 Feb; 1091(3):294-302. PubMed ID: 2001412
[TBL] [Abstract][Full Text] [Related]
9. Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes.
Buss JL; Arduini E; Ponka P
Biochem Pharmacol; 2002 Dec; 64(12):1689-701. PubMed ID: 12445858
[TBL] [Abstract][Full Text] [Related]
10. Effects of chelators on iron uptake and release by the brain in the rat.
Crowe A; Morgan EH
Neurochem Res; 1994 Jan; 19(1):71-6. PubMed ID: 8139766
[TBL] [Abstract][Full Text] [Related]
11. Uptake and intracellular handling of iron from transferrin and iron chelates by mitogen stimulated mouse lymphocytes.
Djeha A; Brock JH
Biochim Biophys Acta; 1992 Jan; 1133(2):147-52. PubMed ID: 1731957
[TBL] [Abstract][Full Text] [Related]
12. Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties.
Buss JL; Neuzil J; Gellert N; Weber C; Ponka P
Biochem Pharmacol; 2003 Jan; 65(2):161-72. PubMed ID: 12504792
[TBL] [Abstract][Full Text] [Related]
13. Influence of cellular iron status on the release of soluble transferrin receptor from human promyelocytic leukemic HL60 cells.
Chitambar CR; Zivkovic-Gilgenbach Z
J Lab Clin Med; 1990 Sep; 116(3):345-53. PubMed ID: 2401848
[TBL] [Abstract][Full Text] [Related]
14. Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH).
Forsbeck K; Bjelkenkrantz K; Nilsson K
Scand J Haematol; 1986 Nov; 37(5):429-37. PubMed ID: 3810041
[TBL] [Abstract][Full Text] [Related]
15. Replacement of transferrin in serum-free cultures of mitogen-stimulated mouse lymphocytes by a lipophilic iron chelator.
Brock JH; Stevenson J
Immunol Lett; 1987 May; 15(1):23-5. PubMed ID: 3610230
[TBL] [Abstract][Full Text] [Related]
16. Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells.
Buss JL; Arduini E; Shephard KC; Ponka P
Biochem Pharmacol; 2003 Feb; 65(3):349-60. PubMed ID: 12527328
[TBL] [Abstract][Full Text] [Related]
17. A lipophilic iron chelator can replace transferrin as a stimulator of cell proliferation and differentiation.
Landschulz W; Thesleff I; Ekblom P
J Cell Biol; 1984 Feb; 98(2):596-601. PubMed ID: 6693498
[TBL] [Abstract][Full Text] [Related]
18. Pyridoxal isonicotinoyl hydrazone and its analogues.
Buss JL; Hermes-Lima M; Ponka P
Adv Exp Med Biol; 2002; 509():205-29. PubMed ID: 12572996
[No Abstract] [Full Text] [Related]
19. Iron delivery during proliferation and differentiation of kidney tubules.
Landschulz W; Ekblom P
J Biol Chem; 1985 Dec; 260(29):15580-4. PubMed ID: 4066687
[TBL] [Abstract][Full Text] [Related]
20. Pyridoxal isonicotinoyl hydrazone (PIH): a promising new iron chelator.
Webb J; Vitolo ML
Birth Defects Orig Artic Ser; 1988; 23(5B):63-70. PubMed ID: 3291971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
